Abstracts tagged "Bone"

Abstract Number: 319 • 2017 ACR/ARHP Annual Meeting
The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab
Felicia Cosman¹, Daria B Crittenden², Serge Ferrari³, Aliya Khan⁴, Nancy E Lane⁵, Kurt Lippuner⁶, Toshio Matsumoto⁷, Cassandra E Milmont², Cesar Libanati⁸ and Andreas Grauer², ¹Helen Hayes Hospital, West Haverstraw, and Columbia University, New York, NY, ²Amgen Inc., Thousand Oaks, CA, ³Geneva University Hospital, Geneva, Switzerland, ⁴McMaster University, Hamilton, ON, Canada, ⁵UC Davis Medical Center, Sacramento, CA, ⁶Osteoporosis Policlinic, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland, ⁷University of Tokushima, Tokushima, Japan, ⁸UCB Pharma, Brussels, Belgium
Background/Purpose: Romosozumab (Romo), a sclerostin antibody, has a dual effect of increasing bone formation and decreasing bone resorption. In the FRAME study, one year of…
Abstract Number: 333 • 2017 ACR/ARHP Annual Meeting
Atypical Femoral Fracture in Patients of a Rheumatology Service: Clinical, Radiographic and Bone Histomorphometric Data
Mariana O Perez¹, Diogo S Domiciano¹, Vanda Jorgetti² and Rosa M R Pereira¹, ¹Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil, ²Nephrology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
Background/Purpose: Atypical femoral fractures (AFF) are low energy femoral fractures with a specific radiographic pattern and subtrochanteric / diaphyseal localization that have been related to…
Abstract Number: 489 • 2017 ACR/ARHP Annual Meeting
Endotypic Clustering of Rheumatoid Arthritis Patients through the Use of Tissue Specific Serum Biomarkers Identifies Structural Progressors
Joseph Patrick Michele Blair¹, Cecilie Liv Bager¹, Line Mærsk Staunstrup¹, Henning Bay Nielsen¹, Morten Karsdal² and Anne-C. Bay-Jensen³, ¹ProScion, Herlev, Denmark, ²Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark, ³Biomarkers and Reseach, Nordic Bioscience, Herlev, Denmark
Background/Purpose: Treatment of RA patients is guided by measures of disease activity such as DAS28, best practice recommendation, and less often by a treat-to-target approach.…
Abstract Number: 656 • 2017 ACR/ARHP Annual Meeting
Prostaglandin E2 and Its Receptor Subtype EP4 Are Involved in Ankylosing Spondylitis Disease Progression
Archita Srinath^1,2,3, Giuliana Guggino⁴, Ismail Sari⁵, Fanxing Zeng⁶, Francesco Ciccia⁴ and Nigil Haroon⁵, ¹Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada, ²Genes and Development, University Health Network, Toronto, ON, Canada, ³Krembil Discovery Tower, Toronto, ON, Canada, ⁴Rheumatology Unit, University of Palermo, Palermo, Italy, ⁵Rheumatology, Toronto Western Hospital, University of Toronto, Spondylitis Clinic, Toronto, ON, Canada, ⁶University Health Network, Toronto, ON, Canada
Background/Purpose: Single Nucleotide Polymorphisms (SNPs) in PTGER4 were found to be associated with Ankylosing spondylitis (AS) in GWAS. PTGER4 codes for the prostaglandin-E2 receptor EP4.…
Abstract Number: 1074 • 2017 ACR/ARHP Annual Meeting
High Cholesterol Levels By ApoE Defenciency Reduce Bone Destruction in Murine Antigen-Induced Arthritis Via Inhibition of Osteoclastogenesis
Giuliana Ascone¹, Irene Di Ceglie¹, Arjen B. Blom¹, Birgitte Walgreen², Annet W. Sloetjes¹, Peter M. van der Kraan¹, Ernst Lindhout³, Mike Martens³ and Peter L. van Lent⁴, ¹Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, ²Experimental, Radboud university medical center, Nijmegen, Netherlands, ³Future Diagnostics Solutions (FDs), Wijchen, Netherlands, ⁴Experimental Rheumatology (272), Radboud university medical center, Nijmegen, Netherlands
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by immune complex- deposition in the synovium, leading to increased bone destruction. In RA, joint…
Abstract Number: 1219 • 2017 ACR/ARHP Annual Meeting
Associations between Muscle Mass and Function with Bone Microarchitecture and Bone Strength in Postmenopausal Women
Daniel Lobo¹, Jackeline C Alvarenga¹, Diogo S Domiciano², Fabiana Benatti¹, Bruno Gualano¹ and Rosa M R Pereira², ¹Rheumatology Division, Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, ²Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil
Background/Purpose: Most studies on sarcopenia and osteoporosis involve elderly populations. However, because postmenopausal hypoestrogenism is able to negatively modulate bone and muscle mass, it is…
Abstract Number: 1225 • 2017 ACR/ARHP Annual Meeting
BONE Mineral Density and Vertebral Fractures in Gaucher Disease Patients Treated with Imiglucerase
Maria Silvia Larroude¹, Gabriel Aguilar¹, Ignacio Rossi¹, Lucas Ricardo Brun² and Guillermo Drelichman³, ¹Centro de Diagnostico Rossi, Buenos Aires, Argentina, ²School of Medicine. Rosario National University, Bone Biology Laboratory, Rosario, Argentina, ³Hospital Ricardo Gutierrez, Buenos Aires, Argentina
Background/Purpose: Osteopenia and osteoporosis (OP) have been described in patients with Gaucher disease (GD) but there are very few reports about bone mass in GD…
Abstract Number: 1899 • 2017 ACR/ARHP Annual Meeting
Osteopontin and Leptin Are Associated with Erosive Disease in an Inception Cohort of Rheumatoid Arthritis Treated-to-Target with Combination Conventional DMARD Therapy
Mihir D. Wechalekar^1,2,3, Susan Lester⁴, Sunil Nagpal⁵, Suzanne Cole⁶, Jessica Peters⁷, Anuk Das⁸, Pravin Hissaria⁹, Tania Crotti¹⁰, Catherine Hill^1,11,12, Sudha Raghunath¹³, Llew Spargo¹⁴, Jennifer G Walker^13,14,15, Malcolm D. Smith² and Susanna Proudman^1,10, ¹Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ²Flinders University, Adelaide, Australia, ³Rheumatology Unit, Repatriation General Hospital, Adelaide, Australia, ⁴Queen Elizabeth Hospital, Adelaide, Australia, ⁵Immunology, Janssen Research & Development, Spring House, PA, ⁶Immunology, Janssen Research and Development, Spring House, PA, ⁷Janssen Research & Development, Spring House, PA, ⁸Janssen R&D, Berwyn, PA, ⁹Immunology, SA Pathology, Adelaide, Australia, ¹⁰University of Adelaide, Adelaide, Australia, ¹¹Medicine, The University of Adelaide, Adelaide, Australia, ¹²The Queen Elizabeth Hospital, Adelaide, Australia, ¹³Repatriation General Hospital, Adelaide, Australia, ¹⁴Rheumatology Unit, Royal Adelaide Hospital, South Australia, Adelaide, Australia, ¹⁵Flinders University of South Australia, Adelaide, Australia
Background/Purpose: We sought to identify biomarkers associated with erosive disease and bone loss in an inception rheumatoid arthritis (RA) cohort receiving treat-to-target combination DMARD therapy…
Abstract Number: 1946 • 2017 ACR/ARHP Annual Meeting
Development of a Multi-Component 3D Arthritic Joint Model
Alexandra Damerau^1,2, Lisa Ehlers^1,2, Moritz Pfeiffenberger^1,2, Igor Ponomarev³, Frank Buttgereit^2,4, Timo Gaber^4,5 and Annemarie Lang^1,2, ¹Rheumatologie und klinische Immunologie, Charité-Universitätsmedizin Berlin, Berlin, Germany, ²Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany, ³Research Center of Medical Technology and Biotechnology, Bad Langensalza, Germany, ⁴Rheumatologie und klinische Immunologie, Charité Universitätsmedizin Berlin, Berlin, Germany, ⁵German Rheumatism Research Center (DRFZ) Berlin, Berlin, Germany
Background/Purpose: Our goal is to develop an in vitro 3D joint model to simulate the immune mediated pathogenesis of arthritides in order to present an…
Abstract Number: 1994 • 2017 ACR/ARHP Annual Meeting
Erosion Depth Predicts Erosion Progression in Patients with Early RA: A Longitudinal Analysis Using HR-pQCT
Jiang YUE¹, James F Griffith², Fan XIAO³, Jiankun XU⁴, Ling Qin⁵ and Lai-Shan Tam⁶, ¹Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, HONGKONG, Hong Kong, ³Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁴Department of Orthopedics & Traumatology, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁵Bone Quality and Health Centre of the Department of Orthopaedics and Traumatology, The Prince of Wales Hospital, The Chinese University of Hong Kong, hongkong, Hong Kong, ⁶Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
Background/Purpose: To ascertain the predictors of erosion progression in patients with early RA using high-resolution peripheral quantitative computed tomography (HR-pQCT). Methods: In this prospective study,…
Abstract Number: 1997 • 2017 ACR/ARHP Annual Meeting
Detection of Progression of Radiographic Damage Despite Early and Targeted Therapy in Inflammatory Arthritis Using High-Resolution Peripheral Quantitative Computed Tomography
Sarah Manske^1,2, Stephanie Finzel³, Steven K. Boyd⁴ and Cheryl Barnabe⁵, ¹Department of Radiology, University of Calgary, Calgary, AB, Canada, ²McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada, ³Department of Rheumatology and Clinical Immunology, Medical Center University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany, ⁴Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, ⁵Division of Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Early initiation of DMARDs and targeted therapy to achieve remission are said to offer the best opportunity to prevent radiographic damage in early inflammatory…
Abstract Number: 2207 • 2017 ACR/ARHP Annual Meeting
Urine CTX-II, CTX-I, Osteocalcin, and Radiographic Severity of Multiple OA Knee Joints: Does CTX-II Originate from Bone or Cartilage?
Asger R. Bihlet¹, Inger Byrjalsen², Anne C. Bay-Jensen³, Jeppe Andersen⁴, Claus Christiansen¹, Bente J. Riis¹ and Morten Asser Karsdal³, ¹Nordic Bioscience, Clinical Development, Herlev, Denmark, ²Nordic Bioscience, Herlev, Denmark, ³Rheumatology, Nordic Bioscience, Herlev, Denmark, ⁴Clinical Development, Nordic Bioscience, Herlev, Denmark
Background/Purpose: Excessive cartilage degradation is a known characteristic of osteoarthritis (OA), and several methods of quantification of cartilage degradation exist. Biomarkers such as urinary C-telopeptide…
Abstract Number: 2228 • 2017 ACR/ARHP Annual Meeting
Involvement of Receptor Tyrosine Kinase a Signaling in Rhumatoid Arthritis Using Trka/C Knock-in Mice: A Multimodal Approach
Lauriane Delay¹, Julie Barbier¹, Ludivine Boudieu¹, Denis Ardid¹, Arnaud Briat², Philippe Auzeloux², Elisabeth Moit-Noirault², Aziz Moqrich³ and Fabien Marchand¹, ¹Inserm U1107 NeuroDol, Université Clermont Auvergne, Clermont-Ferrand, France, ²4UMR 1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, France, ³UMR 6216 CNRS-Université de la Méditerranée, Institut de Biologie du Développement de Marseille Luminy, Marseille, France
Background/Purpose: Rheumatoid Arthritis (RA) is an autoimmune disease very commonly associated with chronic pain which is often resistant to currents analgesics. Targeting Nerve Growth Factor…
Abstract Number: 2941 • 2017 ACR/ARHP Annual Meeting
Effect of Achieving Sustained SDAI Remission on Erosion Repair in Patients with Early RA: A Prospective HR-pQCT Study
Jiang Yue¹, James F Griffith², Fan XIAO³, Ling Qin⁴ and Lai-Shan Tam⁵, ¹Department of Medicine & Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, HONGKONG, Hong Kong, ³Department of Imaging and Interventional Radiology, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ⁴Bone Quality and Health Centre of the Department of Orthopaedics and Traumatology, The Prince of Wales Hospital, The Chinese University of Hong Kong, hongkong, Hong Kong, ⁵Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: To assess whether achieving sustained SDAI remission in patients with early rheumatoid arthritis (ERA) facilitates repair of existing bone erosions as measured by high-resolution…
Abstract Number: 62 • 2017 ACR/ARHP Annual Meeting
Convergence of Joint Repair and Pain Pathways Via Nerve Growth Factor and p75 Expressing Mesenchymal Stem Cells in Established Osteoarthritis
Thomas Baboolal¹, Sumaiya Al Hinai², Elena Jones², Jill Reckless³, Martyn Foster⁴, Rachel Doyle⁵, Kerry af Forselles⁴, Simon Westbrook⁴ and Dennis McGonagle², ¹PhD, Leeds, United Kingdom, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, ³Rxcelerate Ltd, Cambridge, United Kingdom, ⁴Levicept Ltd, Ramsgate, United Kingdom, ⁵Tetrad Discovery Ltd, Ramsgate, United Kingdom
Background/Purpose: Nerve growth factor (NGF) is a key regulator of pain and anti-NGF therapy reduces osteoarthritis (OA) associated pain. However, anti-NGF therapy is associated with…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].